Lung Cancer - Related Resources

Cochrane reviews

No particular radiotherapy regimen appears to provide greater palliation than others for symptoms of patients with non-small cell lung cancer. Patients with better performance status may benefit from the use of high dose palliative regimes Palliative Radiotherapy Regimes for Non-Small Cell Lung Cancer.
Low molecular weight heparin (LMWH) reduces symptomatic venous thromboembolism and increases minor bleeding events in ambulatory cancer patients with no standard therapeutic or prophylactic indication for anticoagulation. LMWH appears to have a survival benefit in patients with small cell lung cancer at 12 monthsParenteral Anticoagulation in Ambulatory Patients with Cancer.
Oral anticoagulation is not effective for prolonging survival in patients with cancer Oral Anticoagulation for Prolonging Survival in Patients with Cancer.
Platinum-based chemotherapy regimens appear not to provide significant benefit over non-platinum regimens for small cell lung cancer in terms of survival but appear to provide better complete tumour response rates Platinum-Based Chemotherapy Regimens for Small-Cell Lung Cancer.
Compared to surgery alone, postoperative radiotherapy decreases survival of patients with early stage completely resected non-small cell lung cancerPostoperative Radiotherapy for Non-Small Cell Lung Cancer.
Screening of asymptomatic individuals for lung cancer with chest radiography, sputum cytology or computed tomography appears not to reduce lung cancer-related mortality. Annual low-dose CT screening appears to be associated with a reduction in lung cancer mortality in high-risk smokers, but further data are required. Screening for Lung Cancer.

OtherInternet resources

Small cell lung cancer. Orphanet ORPHA70573 http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=10953&Disease_Disease_Search_diseaseGroup=Lung-cancer--small-cell&Disease_Disease_Search_diseaseType=Pat&Disease(s) concerned=Lung-cancer--small-cell&title=Lung-cancer--small-cell&searc

Literature

Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004 Oct 1;22(19):3860-7. [PubMed]
Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004 Jan 22;350(4):351-60. [PubMed]
Cufer T, Ovcaricek T, O'Brien ME. Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years. Eur J Cancer 2012 ( Dec 19) [PubMed]
Casaluce F, Sgambato A, Maione P ym. ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC. Target Oncol 2013;8(1):55-67. [PubMed]
Douillard JY, Rosell R, De Lena M et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006 Sep;7(9):719-27. [PubMed]
Thatcher N, Chang A, Parikh P et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005 Oct 29-Nov 4;366(9496):1527-37. [PubMed]
Shepherd FA, Rodrigues Pereira J, Ciuleanu T et al; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005 Jul 14;353(2):123-32. [PubMed]
Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest 2006 Oct;130(4):1211-9. [PubMed]
Bedano PM, Hanna NH. Salvage therapy in patients with advanced non-small cell lung cancer. J Thorac Oncol 2006 Jul;1(6):582-7. [PubMed]

Primary/Secondary Keywords

Related resources

section name header

References

Lung Cancer - Related Resources

Cochrane reviews

OtherInternet resources

Literature